Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LNG Energy Announces Signing of Hydrocarbon Productive Participation Contracts (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Braxia Scientific Corp C.SHRM


Primary Symbol: C.BRAX Alternate Symbol(s):  BRAXF

Braxia Scientific Corp. is a Canada-based company, which is primarily focused on owning and operating multidisciplinary clinics, providing treatment for mental health disorders, and research activities related to discovering and commercializing drugs and delivery methods. The Company seeks to develop ketamine and derivatives and other psychedelic products from its Internet protocol (IP) development platform. The Company has clinic operations in the Canadian cities of Mississauga, Toronto, Kitchener-Waterloo, Ottawa and Montreal. The Company, through its wholly owned subsidiary, the Canadian Rapid Treatment Center of Excellence Inc., it operates multidisciplinary community-based clinics offering rapid-acting treatments for depression located in Mississauga, Toronto, Ottawa, Kitchener and Montreal. Its subsidiaries include Altmed Capital Corp., Artisan Growers Ltd., KetaMD, Inc., Novo Formulations Ltd. and Tassili Life Sciences Corp.


CSE:BRAX - Post by User

Braxia Scientific Corp
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(180)
•••
Post by newcoinon Apr 24, 2021 5:29pm
334 Views
Post# 33062189

Part of the Psychedelic Community

Part of the Psychedelic CommunityNUMI just hit the NY Times.

Interesting to do a quick comparison. Very similiar Canadian psychedelic company (not sure of revenues). They have roughly the same number of shares outstanding. Higher market cap. They just did a $40M raise at $1.25/unit. Trading at $1.08.

Makes you realize how fast these exciting companies can go up in value.

https://numinus-5982382.hs-sites.com/numi-news-in-new-york-times?ecid=ACsprvtZlrvAg_X08qF0B9utzowbl4s6xLERauC5JiIjaepvyGiC7W0eJrdnQj5b3-h8FTqCucKy&utm_campaign=Newsletter&utm_medium=email&_hsmi=123249889&_hsenc=p2ANqtz-_JrYDpUhWYxJkehYH6hL1yNMsKyLn0kW42arNfd-nPYCduyvBK-Og8GIwyeMVC7OLTycJB4o4J0m2MElNAgJA67xbYaA&utm_content=123249889&utm_source=hs_email
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities